Sunday, November 28, 2021

Sputnik V

Apollo Hospitals partners with Dr Reddy’s to administer Sputnik V vaccines

Pilot programme to administer from the first batch of 1,50,000 doses of Sputnik V vaccines imported from RDIF

Dr Reddy’s Laboratories gearing up with Covid portfolio

Plan to vaccinate 125 million people in the next 8-12 months across the country

Dr Reddy’s administers first dose of Sputnik V vaccine in Hyderabad

The imported doses of the vaccine are presently priced at Rs 995 (Rs 948 plus 5 per cent GST per dose), with the possibility of a lower price point when local supply begins.

GMR Hyderabad Air Cargo enhancing Covid vaccine handling capability

Hyderabad is set to be the single largest concentration of Covid-19 vaccine manufacturing capacities globally

Russian Sputnik-V vaccine arrives in Hyderabad

Hyderabad-based Dr Reddy’s Laboratories has collaborated with RDIF to import the first consignment of Sputnik-V while it is expected that the pharma giant will start manufacturing from its local facilities in India

Dr Reddy’s expects first lot of Russia’s COVID-19 vaccine Sputnik V by May end

RDIF CEO Kirill Dmitriev in a virtual press conference recently said he expected over 50 million doses of Sputnik V vaccine to be manufactured in India by this summer.

Delayed move

Govt must now work out a mutually agreeable pricing and procurement strategy for a smooth rollout of the foreign vaccines

DCGI accords Dr. Reddy’s permission to import Sputnik V

According to the Hyderabad-based company, emergency use will be as per the provisions of the new drug and clinical trials rules, 2019 under the Drugs and Cosmetics Act

India to produce 850 million Sputnik doses annually: RDIF

India has become the 60th country to approve Sputnik V, RDIF, Russia's sovereign wealth fund, said in a statement.

Russia’s Sputnik V gets Emergency Use Authorisation nod in India

The decision comes after the Drugs Controller General of India (DCGI)'s SEC met today to take up Sputnik V application for EUA in India.

RDIF, Hyderabad-based Virchow Biotech ink pact to produce Sputnik V vaccine in India

Four companies developing Covid vaccines in India are based in Hyderabad

Western groups plan disinformation campaign against Russian vax

Such a campaign was made by non-governmental organisations and media in the West, the outlets reported on Friday citing a high-ranking source in the Kremlin as saying.

C-vax: WHO chief appreciates Russia’s investment in science

I had a constructive call with Mihail Murashko (Mikhail Murashko), Russia's Health Minister, about the Covid19 response globally & in Russia, as well as about the Sputnik V vaccine & the WHO Emergency Use Listing process for vaccines.

Dr Reddy’s Lab seeks emergency use authorisation for Sputnik V

As part of the review process, the drug major will present the safety profile of phase 2 study, and interim data of phase 3 trial, which is expected to be complete by February 21

Sputnik V vaccine shows 91.6% efficacy in phase 3 trials: Lancet

Data on 19,866 volunteers were included in the efficacy analysis - 14,964 of whom received the vaccine and 4,902 the placebo.

Latest News

- Advertisement -